Cargando…

Bioimpedance Analysis–Guided Volume Expansion for the Prevention of Contrast-Induced Acute Kidney Injury (the BELIEVE Pilot Randomized Controlled Trial)

INTRODUCTION: Peri-procedural i.v. fluid administration is important for the prevention of contrast-induced acute kidney injury (CI-AKI). However, standardized fluid management protocols may not be suitable for all patients. We therefore wished to determine whether an individualized fluid administra...

Descripción completa

Detalles Bibliográficos
Autores principales: Kananuraks, Sarassawan, Assanatham, Montira, Boongird, Sarinya, Kitiyakara, Chagriya, Thammavaranucupt, Kanin, Limpijarnkij, Thosaphol, Warodomwichit, Daruneewan, Davenport, Andrew, Nongnuch, Arkom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486189/
https://www.ncbi.nlm.nih.gov/pubmed/32954073
http://dx.doi.org/10.1016/j.ekir.2020.07.009
_version_ 1783581296839098368
author Kananuraks, Sarassawan
Assanatham, Montira
Boongird, Sarinya
Kitiyakara, Chagriya
Thammavaranucupt, Kanin
Limpijarnkij, Thosaphol
Warodomwichit, Daruneewan
Davenport, Andrew
Nongnuch, Arkom
author_facet Kananuraks, Sarassawan
Assanatham, Montira
Boongird, Sarinya
Kitiyakara, Chagriya
Thammavaranucupt, Kanin
Limpijarnkij, Thosaphol
Warodomwichit, Daruneewan
Davenport, Andrew
Nongnuch, Arkom
author_sort Kananuraks, Sarassawan
collection PubMed
description INTRODUCTION: Peri-procedural i.v. fluid administration is important for the prevention of contrast-induced acute kidney injury (CI-AKI). However, standardized fluid management protocols may not be suitable for all patients. We therefore wished to determine whether an individualized fluid administration protocol guided by measuring extracellular water (ECW) using bioimpedance analysis (BIA) would be safe and would reduce the incidence CI-AKI compared to a standardized fluid administration prescription. METHODS: In this pilot, randomized, parallel-group, single-blind, controlled trial, we compared the effect of BIA-guided isotonic bicarbonate administration according to the ratio of ECW to total body water (ECW/TBW) to our standard isotonic bicarbonate protocol in regard to the safety and efficacy of preventing CI-AKI in chronic kidney disease patients undergoing elective cardiac angiography. Our primary outcome was the incidence of CI-AKI, which was defined as a ≥0.3 mg/dl or 150% increase in serum creatinine concentration within 48 to 72 hours after cardiac angiography. RESULTS: We studied 61 patients, 30 in the bioimpedance group and 31 in the control group. Age was similar (72.5 ± 7 vs. 71.4 ± 7.9 years), as were body mass index (25.5 vs. 25.8 kg/m(2)) and baseline serum creatinine (1.3 ± 0.3 vs. 1.4 ± 0.4 mg/dl). The peri-procedural fluid volume administered was significantly greater in the BIA-guided hydration group (899.0 ± 252.7 ml vs. 594.4 ± 125.9 ml, P < .01). The incidence of CI-AKI was 3.3% in BIA-guided hydration group and 6.5% in the control group (relative risk = 0.52, 95% confidence interval = 0.05−5.40, P = 1.00). Adverse events reported were comparable between groups (6.7% vs. 6.5%, P = 1.00). CONCLUSIONS: The overall incidence of CI-AKI after cardiac angiography in our patients with mild-to-moderate renal insufficiency was lower than anticipated. Isotonic bicarbonate administration guided by bioimpedance measurements was safe, and probably led to a lower incidence of CI-AKI, although this not reach statistical significance.
format Online
Article
Text
id pubmed-7486189
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-74861892020-09-17 Bioimpedance Analysis–Guided Volume Expansion for the Prevention of Contrast-Induced Acute Kidney Injury (the BELIEVE Pilot Randomized Controlled Trial) Kananuraks, Sarassawan Assanatham, Montira Boongird, Sarinya Kitiyakara, Chagriya Thammavaranucupt, Kanin Limpijarnkij, Thosaphol Warodomwichit, Daruneewan Davenport, Andrew Nongnuch, Arkom Kidney Int Rep Clinical Research INTRODUCTION: Peri-procedural i.v. fluid administration is important for the prevention of contrast-induced acute kidney injury (CI-AKI). However, standardized fluid management protocols may not be suitable for all patients. We therefore wished to determine whether an individualized fluid administration protocol guided by measuring extracellular water (ECW) using bioimpedance analysis (BIA) would be safe and would reduce the incidence CI-AKI compared to a standardized fluid administration prescription. METHODS: In this pilot, randomized, parallel-group, single-blind, controlled trial, we compared the effect of BIA-guided isotonic bicarbonate administration according to the ratio of ECW to total body water (ECW/TBW) to our standard isotonic bicarbonate protocol in regard to the safety and efficacy of preventing CI-AKI in chronic kidney disease patients undergoing elective cardiac angiography. Our primary outcome was the incidence of CI-AKI, which was defined as a ≥0.3 mg/dl or 150% increase in serum creatinine concentration within 48 to 72 hours after cardiac angiography. RESULTS: We studied 61 patients, 30 in the bioimpedance group and 31 in the control group. Age was similar (72.5 ± 7 vs. 71.4 ± 7.9 years), as were body mass index (25.5 vs. 25.8 kg/m(2)) and baseline serum creatinine (1.3 ± 0.3 vs. 1.4 ± 0.4 mg/dl). The peri-procedural fluid volume administered was significantly greater in the BIA-guided hydration group (899.0 ± 252.7 ml vs. 594.4 ± 125.9 ml, P < .01). The incidence of CI-AKI was 3.3% in BIA-guided hydration group and 6.5% in the control group (relative risk = 0.52, 95% confidence interval = 0.05−5.40, P = 1.00). Adverse events reported were comparable between groups (6.7% vs. 6.5%, P = 1.00). CONCLUSIONS: The overall incidence of CI-AKI after cardiac angiography in our patients with mild-to-moderate renal insufficiency was lower than anticipated. Isotonic bicarbonate administration guided by bioimpedance measurements was safe, and probably led to a lower incidence of CI-AKI, although this not reach statistical significance. Elsevier 2020-07-17 /pmc/articles/PMC7486189/ /pubmed/32954073 http://dx.doi.org/10.1016/j.ekir.2020.07.009 Text en © 2020 International Society of Nephrology. Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Clinical Research
Kananuraks, Sarassawan
Assanatham, Montira
Boongird, Sarinya
Kitiyakara, Chagriya
Thammavaranucupt, Kanin
Limpijarnkij, Thosaphol
Warodomwichit, Daruneewan
Davenport, Andrew
Nongnuch, Arkom
Bioimpedance Analysis–Guided Volume Expansion for the Prevention of Contrast-Induced Acute Kidney Injury (the BELIEVE Pilot Randomized Controlled Trial)
title Bioimpedance Analysis–Guided Volume Expansion for the Prevention of Contrast-Induced Acute Kidney Injury (the BELIEVE Pilot Randomized Controlled Trial)
title_full Bioimpedance Analysis–Guided Volume Expansion for the Prevention of Contrast-Induced Acute Kidney Injury (the BELIEVE Pilot Randomized Controlled Trial)
title_fullStr Bioimpedance Analysis–Guided Volume Expansion for the Prevention of Contrast-Induced Acute Kidney Injury (the BELIEVE Pilot Randomized Controlled Trial)
title_full_unstemmed Bioimpedance Analysis–Guided Volume Expansion for the Prevention of Contrast-Induced Acute Kidney Injury (the BELIEVE Pilot Randomized Controlled Trial)
title_short Bioimpedance Analysis–Guided Volume Expansion for the Prevention of Contrast-Induced Acute Kidney Injury (the BELIEVE Pilot Randomized Controlled Trial)
title_sort bioimpedance analysis–guided volume expansion for the prevention of contrast-induced acute kidney injury (the believe pilot randomized controlled trial)
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486189/
https://www.ncbi.nlm.nih.gov/pubmed/32954073
http://dx.doi.org/10.1016/j.ekir.2020.07.009
work_keys_str_mv AT kananurakssarassawan bioimpedanceanalysisguidedvolumeexpansionforthepreventionofcontrastinducedacutekidneyinjurythebelievepilotrandomizedcontrolledtrial
AT assanathammontira bioimpedanceanalysisguidedvolumeexpansionforthepreventionofcontrastinducedacutekidneyinjurythebelievepilotrandomizedcontrolledtrial
AT boongirdsarinya bioimpedanceanalysisguidedvolumeexpansionforthepreventionofcontrastinducedacutekidneyinjurythebelievepilotrandomizedcontrolledtrial
AT kitiyakarachagriya bioimpedanceanalysisguidedvolumeexpansionforthepreventionofcontrastinducedacutekidneyinjurythebelievepilotrandomizedcontrolledtrial
AT thammavaranucuptkanin bioimpedanceanalysisguidedvolumeexpansionforthepreventionofcontrastinducedacutekidneyinjurythebelievepilotrandomizedcontrolledtrial
AT limpijarnkijthosaphol bioimpedanceanalysisguidedvolumeexpansionforthepreventionofcontrastinducedacutekidneyinjurythebelievepilotrandomizedcontrolledtrial
AT warodomwichitdaruneewan bioimpedanceanalysisguidedvolumeexpansionforthepreventionofcontrastinducedacutekidneyinjurythebelievepilotrandomizedcontrolledtrial
AT davenportandrew bioimpedanceanalysisguidedvolumeexpansionforthepreventionofcontrastinducedacutekidneyinjurythebelievepilotrandomizedcontrolledtrial
AT nongnucharkom bioimpedanceanalysisguidedvolumeexpansionforthepreventionofcontrastinducedacutekidneyinjurythebelievepilotrandomizedcontrolledtrial